| Literature DB >> 33106639 |
Yezhang Ding1, Philipp R Weckwerth1, Elly Poretsky1, Katherine M Murphy2, James Sims3, Evan Saldivar1, Shawn A Christensen4, Si Nian Char5, Bing Yang5,6, Anh-Dao Tong1, Zhouxin Shen1, Karl A Kremling7, Edward S Buckler7,8, Tom Kono9, David R Nelson10, Jörg Bohlmann11, Matthew G Bakker12,13, Martha M Vaughan12, Ahmed S Khalil1, Mariam Betsiashvili1, Keini Dressano1, Tobias G Köllner14, Steven P Briggs1, Philipp Zerbe2, Eric A Schmelz1, Alisa Huffaker15.
Abstract
Specialized metabolites constitute key layers of immunity that underlie disease resistance in crops; however, challenges in resolving pathways limit our understanding of the functions and applications of these metabolites. In maize (Zea mays), the inducible accumulation of acidic terpenoids is increasingly considered to be a defence mechanism that contributes to disease resistance. Here, to understand maize antibiotic biosynthesis, we integrated association mapping, pan-genome multi-omic correlations, enzyme structure-function studies and targeted mutagenesis. We define ten genes in three zealexin (Zx) gene clusters that encode four sesquiterpene synthases and six cytochrome P450 proteins that collectively drive the production of diverse antibiotic cocktails. Quadruple mutants in which the ability to produce zealexins (ZXs) is blocked exhibit a broad-spectrum loss of disease resistance. Genetic redundancies ensuring pathway resiliency to single null mutations are combined with enzyme substrate promiscuity, creating a biosynthetic hourglass pathway that uses diverse substrates and in vivo combinatorial chemistry to yield complex antibiotic blends. The elucidated genetic basis of biochemical phenotypes that underlie disease resistance demonstrates a predominant maize defence pathway and informs innovative strategies for transferring chemical immunity between crops.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33106639 DOI: 10.1038/s41477-020-00787-9
Source DB: PubMed Journal: Nat Plants ISSN: 2055-0278 Impact factor: 15.793